-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

322.O1.6 322. Disorders of Coagulation or Fibrinolysis: Von Willebrand Disease and Bleeding

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Adult, Bleeding Disorders, antibodies, Bleeding and Clotting, Diseases, Non-Biological, Therapies, Genetic Disorders, Pediatric, Biological Processes, coagulant drugs, Study Population, Clinically relevant, VWD, pathogenesis, pathways
Monday, December 7, 2020: 9:00 AM-10:30 AM
Moderators:
Ayesha Zia, University of Southwestern Medical Center and Kristina M. Haley, DO, Oregon Health Science University
Disclosures:
No relevant conflicts of interest to declare.
9:00 AM

Ferdows Atiq1*, Johan Boender, MD1*, Marjon H. Cnossen, MD, PhD2*, Johanna G van der Bom, MD, PhD3,4*, Karin Fijnvandraat, MD, PhD5,6*, Joke de Meris7*, Moniek P.M. de Maat, PhD1*, Karin P.M. Van Galen, MD, MSc, PhD8*, Britta A.P. Laros-Van Gorkom, MD, PhD9*, Karina Meijer, MD, PhD10, Jeroen C.J. Eikenboom, MD, PhD11,12 and Frank W.G. Leebeek, MD, PhD1

1Dept. of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands
2Dept. of Pediatric Hematology, Erasmus MC–Sophia Children’s Hospital, University Medical Center Rotterdam, Rotterdam, Netherlands
3Sanquin Research, Center for Clinical Transfusion Research, and Jon J van Rood Center for Clinical Transfusion Science, Leiden University Medical Center, Leiden, Netherlands
4Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, Netherlands
5Dept. of Plasma Proteins, Sanquin Research, Amsterdam, Amsterdam, Netherlands
6Pediatric Hematology, Amsterdam UMC, University of Amsterdam, Emma Children’s Hospital, Amsterdam, Netherlands
7Netherlands Hemophilia Society, Zoetermeer, Netherlands
8Van Creveldkliniek, University Medical Center, University Utrecht, Utrecht, Netherlands
9Dept. of Hematology, Radboud University Medical Center, Nijmegen, Netherlands
10Dept. of Hematology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands
11Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, Netherlands
12Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, Netherlands

9:15 AM

Dino Mehic, MD1*, Stefanie Hofer, PhD1*, Christof Jungbauer, MD2*, Alexandra Kaider3*, Helmuth Haslacher, MD4*, Ernst Eigenbauer5*, Judit Rejtoe, MD1*, Dieter Schwartz, MD6*, Bernd Jilma7, Cihan Ay, MD1*, Ingrid Pabinger, MD8 and Johanna Gebhart, MD, PhD1*

1Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria
2Austrian Red Cross, Blood Service For Vienna, Lower Austria and Burgenland, Vienna, Austria
3Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria
4Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria
5IT-Systems and Communications, Medical University of Vienna, Vienna, AUT
6Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria
7Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
8Department of Medicine I, Clinical Divison of Haematology and Haemostaseology, Medical University of Vienna, Vienna, Austria

9:30 AM

Ferdows Atiq1*, Esmee Wuijster, BSc1*, Moniek P.M. de Maat, PhD1*, Marieke J.H.A. Kruip, MD, PhD1*, Marjon H. Cnossen, MD, PhD2* and Frank W.G. Leebeek, MD, PhD1

1Dept. of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands
2Dept. of Pediatric Hematology, Erasmus MC–Sophia Children’s Hospital, University Medical Center Rotterdam, Rotterdam, Netherlands

9:45 AM

Brooke Sadler, PhD1, Charles Minard, PhD2*, Gabe Haller3*, Christina Gurnett4*, Sarah H. O'Brien, MD5, Allison P. Wheeler, MD6, Eric S. Mullins, MD7, Mukta Sharma, MD, MPH8, Robert F. Sidonio Jr., MD, MSc.9, Shilpa Jain10, Ayesha Zia11, Margaret V. Ragni, MD, MPH12, Roshni Kulkarni, MD13, Jennifer Dietrich14*, Peter A. Kouides, MD15, Jorge Di Paola16* and Lakshmi Srivaths, MD17

1Washington University, Saint Louis, MO
2Dan L. Duncan Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX
3Departments of Neurosurgery, Neurology and Genetics, Washington University, St Louis, MO
4Departments of Pediatrics, Neurology and Orthopaedic Surgery., Washington University, St Louis, MO
5Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio, Nationwide Children's Hospital, Columbus, OH
6Dept. of Pediatric Hem./Onc., Monroe Carell Jr. Children’s Hospital at Vanderbilt, Nashville, TN
7Division of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
8Children’s Mercy Hospital, Kansas City, MO
9Emory University, Aflac Cancer and Blood Disorders, ATLANTA, GA
10University at Buffalo, Buffalo, NY
11University of Southwestern Medical Center, Dallas, TX
12Department of Medicine - Division of Hematology/Oncology, University of Pittsburgh, Pittsburgh, PA
13Michigan State University Center for Bleeding and Clotting Disorders, East Lansing, MI
14Baylor College of Medicine, Houston, TX
15Department of Medicine, Mary M. Gooley Hemophilia Center, Rochester, NY
16Washington University in St. Louis, Saint Louis, MO
17Baylor College of Medicine / Texas Children's Hospital, Houston, TX

10:00 AM

Assaf Arie Barg1,2*, Gili Kenet3, Tami Livnat4*, Einat Avishai5*, Ivan Budnik, MD PhD6*, Tami Brutman-Barazani7*, Ilia Tamarin8*, Aharon Lubetsky9*, Dalia Bashari9*, Rima Dardik, PhD10*, Shadan Lalezari11* and Mudi Misgav12,13*

1Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
2National Hemophilia Center and Coagulation Center and Amalia Biron Res Inst of Thromb & Hemost and Department of Pediatric Hematology-Oncology, Safra Children's Hospital, Tel Hashomer Medical Center, Ramat Gan, Israel
3Israel National Hemophilia Center and Thrombosis Institute, Chaim Sheba Medical Center, Tel Hashomer, Israel
4Israel National Hemophilia Center, Chaim Sheba Medical Center, Tel Hashomer and The Amalia Biron Thrombosis Research Institute, Tel Aviv, Israel
5The Israeli National Hemophilia Center and Thrombosis Unit, Ramat Gan, ISR
6Sechenov First Moscow State Medical University, Moscow, Russian Federation
7National Hemophilia Center and Thrombosis Unit and Amalia Biron Res Inst of Thromb & Hemost, Tel Hashomer, Israel
8The Israeli National Hemophilia Center affiliated to the Tel Aviv University, Ramat Gan, Israel
9The Israeli National Hemophilia Center affiliated to Tel Aviv University, Ramat Gan, Israel
10Sheba Medical Center, Tel Hashomer, Israel
11The Israel National Hemophilia Center and Thrombosis Unit, Chaim Sheba Medical Center, Tel Hashomer, Israel
12National Hemophilia Center and Institute of Thrombosis & Hemostasis, Sheba Medical Center, Tel-Hashomer, Israel
13Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

*signifies non-member of ASH